Weighing Obesity Risk: FDA, EMEA Use Different Scales For Abbott's Meridia
This article was originally published in The Pink Sheet Daily
Executive Summary
After additional cardiovascular events are seen, European regulators move to pull sibutramine, while FDA asks for a contraindication.